India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

In a significant breakthrough for those suffering from chronic hand eczema, a widespread skin condition resistant to existing ...

Precision BioSciences (Nasdaq: DTIL) has received approval in Hong Kong to begin clinical trials evaluating a gene editing ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers ...

PainReform previously disclosed initial topline data from its Phase 3 clinical trial in which it reported that it demonstrated statistically significant superiority over placebo in reducing pain ...

In January 2024, the FDA approved erdafitinib (Balversa) for adult patients with locally advanced or metastatic urothelial ...

A new migraine pill offers rapid relief, significantly reducing the number of migraine days and side effects, according to a recent study.

Strategically incorporating color in health care spaces can potentially increase patient comfort and improve overall ...

Young adults face rising cancer rates — and barriers to timely interventions. From now until the end of the year, all ...